An experimental weight-loss drug from Eli Lilly & Co. helped patients lose weight with few side effects, according to the ...

GoodRx says that with the support of a healthcare team, a clear transition plan, and a few cost-saving tools, you can make ...

Metsera is advancing promising obesity treatments with amylin and GLP-1 analogs, eyeing competitive efficacy and buyout ...

A new study found that weight-loss medications like Ozempic and Mounjaro are not as effective in a “real-world” setting ...

Body image is part physical and part mental. If weight loss alone isn't helping, strategies from body image psychology can ...

“We now have more than one highly effective option, and Zepbound seems to be leading ... As more options become available, patients and providers can better tailor treatment to individual ...

Tufts University scientists are aiming to revolutionize the future of weight loss drugs by engineering a new compound that ...

SEATTLE -- Weight loss drugs have gained momentum as treatment for obstructive sleep apnea (OSA) at sleep clinics across the country -- although patients appear more ready for the shift than the ...

GLP-1 medications offer promising benefits for obesity and diabetes patients, with studies showing reduced heart attack risk ...

Options are emerging for the tens of millions of people who stop taking GLP-1 drugs because of side effects, cost or ...

Providers of compounded obesity drugs are finding—for now—a new way into the booming market by tweaking formulations.

The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to halt the sale and production of off-brand products that many patients in ...